Industry Updates
Press Releases
Medtronic receives breakthrough device designation from FDA, begins early feasibility study for Investigational Intrepid Transcatheter Valve System for the treatment of Tricuspid Valve Regurgitation
Medtronic plc, a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of...
Press Releases
KFM harnesses new technology to help clinicians spend more time with patients
Clinicians at one of London’s largest and busiest hospitals are now spending more time with patients after KFM started using Microsoft technology to ensure staff...
Press Releases
Introducing DuPont Liveo for healthcare silicone solutions
DuPont, a globally recognized leader in silicone-based technology with more than 70 years of experience advancing healthcare through materials innovation, is introducing DuPont™ Liveo™, a...
Press Releases
Qualtrics Announces Partnership With Safe & Reliable Healthcare to Accelerate Healthcare Experience Transformation
Qualtrics, the creator of the experience management (XM) category, announced a partnership with Safe & Reliable Healthcare (S&R), a leading provider of patient safety and...
Press Releases
Change Healthcare Awarded Multi-Year Contracts by Vizient
Change Healthcare announced that it has been awarded two multi-year contracts with Vizient, Inc., the largest healthcare purchasing group in the country. The agreements give...
Press Releases
QT Ultrasound to Bring Breast Imaging Innovation to Asia Through Joint Venture with TCL Healthcare Equipment
QT Ultrasound®, developer of the QTscan®, will bring its radiation- and compression-free 3D breast imaging technology to China, and other Asian markets, through a partnership...
Press Releases
Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets in Japan
Eisai Co., Ltd. announced that it will take over by transfer the manufacturing and marketing approval of Parkinson's disease treatment Equfina 50mg TABLETS (safinamide mesilate,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.